Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
Authors
Keywords
-
Journal
CNS DRUGS
Volume 37, Issue 10, Pages 867-881
Publisher
Springer Science and Business Media LLC
Online
2023-10-04
DOI
10.1007/s40263-023-01032-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial
- (2022) Herriot Tabuteau et al. AMERICAN JOURNAL OF PSYCHIATRY
- Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
- (2022) Yazen Alnefeesi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?
- (2022) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
- (2022) Peng Ren et al. Frontiers in Pharmacology
- Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode
- (2022) Taeho Greg Rhee et al. JAMA Psychiatry
- Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials
- (2021) Amna Majeed et al. EXPERT OPINION ON EMERGING DRUGS
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression
- (2021) Kristine Hole et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
- (2021) Ajay Sarawagi et al. Frontiers in Psychiatry
- Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule
- (2021) Adejoke Yetunde Onaolapo et al. World Journal of Psychiatry
- Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial
- (2020) Sheng-Yu Lee et al. International Journal of Bipolar Disorders
- Major depressive disorder and impaired health‐related quality of life among US older adults
- (2020) Taeho Greg Rhee et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Brain NMDA Receptors in Schizophrenia and Depression
- (2020) Albert Adell Biomolecules
- The clinical characterization of the adult patient with depression aimed at personalization of management
- (2020) Mario Maj et al. World Psychiatry
- Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: Economic burden and healthcare resource utilization
- (2020) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis
- (2019) Dorian A. Rosen et al. Science Translational Medicine
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study
- (2019) Dena H. Jaffe et al. BMC Psychiatry
- Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
- (2019) Stephen M. Stahl CNS SPECTRUMS
- The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
- (2019) Meysam Amidfar et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
- (2018) Sho Moriguchi et al. MOLECULAR PSYCHIATRY
- Blockade of nicotinic acetylcholine receptor enhances the responsiveness to bupropion in the mouse forced swim test
- (2018) Deniz Bagdas et al. BEHAVIOURAL BRAIN RESEARCH
- Depression Is the Leading Cause of Disability Around the World
- (2017) M.J. Friedrich JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
- (2017) Shi Yu Chan et al. Frontiers in Molecular Neuroscience
- Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model
- (2017) Caifu Xue et al. Pharmaceutics
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Raymond W. Lam et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
- (2016) Linda Nguyen et al. PHARMACOLOGY & THERAPEUTICS
- Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
- (2016) Charles P. Taylor et al. PHARMACOLOGY & THERAPEUTICS
- Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice
- (2015) Linda Nguyen et al. BEHAVIOURAL BRAIN RESEARCH
- Antidepressant-like effect of PRE-084, a selective σ1 receptor agonist, in Albino Swiss and C57BL/6J mice
- (2014) Grażyna Skuza et al. Pharmacological Reports
- Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
- (2014) Linda Nguyen et al. PLoS One
- COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS
- (2013) Roger S. McIntyre et al. DEPRESSION AND ANXIETY
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
- (2013) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Cell atrophy and loss in depression: reversal by antidepressant treatment
- (2011) Mounira Banasr et al. CURRENT OPINION IN CELL BIOLOGY
- Dextromethorphan to dextrorphan: a pathway towards abuse liability
- (2011) Shannon C. Miller HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Sigma receptors: Potential targets for a new class of antidepressant drug
- (2010) James A. Fishback et al. PHARMACOLOGY & THERAPEUTICS
- Effect of metabolic blockade on the psychoactive effects of dextromethorphan
- (2009) Laurie A. Zawertailo et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor
- (2008) Ashish Dhir et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More